Biosimilars: EU Payer Perspectives gives the inside track on the biosimilars market today, offering new information to help you stay ahead. For this report, we’ve spoken directly to 10 high-profile payer decision-makers and reimbursement influencers across Europe.
These are the people who define and execute the formulary decisions and payer strategies that reverberate across the pharma landscape. What they think matters.
This 87-page report covers how the European market has changed over the last 12 months as well as offering expert payer views on current practice and what is likely to happen next.
Key issues discussed include regulatory policy and frameworks, commercial tactics and pipeline launches.
- 20 current issues of most interest to pharma were uncovered during preliminary research
- We used these to pose an average of 36 targeted questions of each expert
- Their responses provided 37 unique new insights
- Insights are supported by 242 directly quoted comments